Director Todd Krasnow filed a Form 4 with the SEC on November 4, 2026, disclosing transactions in Symbotic Inc. (NASDAQ:SYM) Class A Common Stock and Symbotic Holdings Units dated November 2, 2026.
Symbotic Inc. officer Michael Dunn filed a Form 144 notice of proposed sale on November 4, 2026, disclosing plans to sell 1,513 shares of Symbotic common stock on NASDAQ under Rule 144 of the Securities Act of 1933.
Omada Health, Inc. director and officer Sean Duffy filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 12,944 shares of common stock acquired through the exercise of stock options on the same date.
Director Kevin J. O'Connor of Procore Technologies, Inc. filed a Form 4 on November 4, 2026, disclosing four sales of Procore common stock totaling 15,384 shares across November 2 and November 3, 2026, all executed under a Rule 10b5-1 plan.
Procore Technologies, Inc. director Elisa Steele filed a Form 144 notice of proposed sale of 3,337 shares of common stock, dated November 4, 2026, with an aggregate market value of $230,586.70.
Hans van Houte, Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), filed a Form 4 on November 4, 2026, disclosing the sale of 4,769 shares of common stock in two transactions executed under a Rule 10b5-1 trading plan.
Nurix Therapeutics, Inc. officer Johannes van Houte filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 4,769 shares of common stock acquired through restricted stock units, with an aggregate market value of $123,135.58.
Director Laura Hay filed a Form 144 notice with the SEC on November 4, 2026, disclosing a proposed sale of 144 shares of Everest Group, Ltd. common stock on the New York Stock Exchange.
Houlihan Lokey Inc. officer Christopher Crain filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 2,000 shares of Houlihan Lokey common stock on NYSE, with an aggregate market value of $293,480.00.
General Motors Company officer Rory Harvey filed a Form 144 Notice of Proposed Sale of Securities with the SEC on November 4, 2026, disclosing plans to sell 16,513 shares of General Motors common stock on the NYSE.